Role of heparan sulfate in fibroblast growth factor signalling: a structural view.

[1]  G. Giménez-Gallego,et al.  Sequence Analysis of Heparan Sulfate Epitopes with Graded Affinities for Fibroblast Growth Factors 1 and 2* , 2001, The Journal of Biological Chemistry.

[2]  M. Mohammadi,et al.  Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[3]  R. Vivès,et al.  Regulation of FGF-1 mitogenic activity by heparan sulfate oligosaccharides is dependent on specific structural features: differential requirements for the modulation of FGF-1 and FGF-2. , 2000, Glycobiology.

[4]  David F. Burke,et al.  Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin , 2000, Nature.

[5]  J. Schlessinger,et al.  Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. , 2000, Molecular cell.

[6]  M. Salmivirta,et al.  Selectively Desulfated Heparin Inhibits Fibroblast Growth Factor-induced Mitogenicity and Angiogenesis* , 2000, The Journal of Biological Chemistry.

[7]  Joseph Schlessinger,et al.  Crystal Structures of Two FGF-FGFR Complexes Reveal the Determinants of Ligand-Receptor Specificity , 2000, Cell.

[8]  D. Ornitz,et al.  FGFs, heparan sulfate and FGFRs: complex interactions essential for development. , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.

[9]  W. Hendrickson,et al.  Structural interactions of fibroblast growth factor receptor with its ligands. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[10]  J. Turnbull,et al.  Fibroblast growth factor receptor signalling is dictated by specific heparan sulphate saccharides , 1999, Current Biology.

[11]  S. Hubbard,et al.  Structural Basis for FGF Receptor Dimerization and Activation , 1999, Cell.

[12]  R. Pettersson,et al.  Characterization of fibroblast growth factor 1 binding heparan sulfate domain. , 1999, Glycobiology.

[13]  J. Gallagher,et al.  Monomer Complexes of Basic Fibroblast Growth Factor and Heparan Sulfate Oligosaccharides Are the Minimal Functional Unit for Cell Activation* , 1999, The Journal of Biological Chemistry.

[14]  J. Turnbull,et al.  Heparan Sulfate Oligosaccharides Require 6-O-Sulfation for Promotion of Basic Fibroblast Growth Factor Mitogenic Activity* , 1998, The Journal of Biological Chemistry.

[15]  Wayne A. Hendrickson,et al.  Structure of a heparin-linked biologically active dimer of fibroblast growth factor , 1998, Nature.

[16]  R. Powers,et al.  Properly oriented heparin-decasaccharide-induced dimers are the biologically active form of basic fibroblast growth factor. , 1997, Biochemistry.

[17]  D C Rees,et al.  Heparin Structure and Interactions with Basic Fibroblast Growth Factor , 1996, Science.

[18]  K. Yoshida,et al.  Importance of 2-O-sulfate groups of uronate residues in heparin for activation of FGF-1 and FGF-2. , 1995, Journal of biochemistry.

[19]  M. Jaye,et al.  Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation , 1994, Cell.

[20]  M. Ishihara Structural requirements in heparin for binding and activation of FGF-1 and FGF-4 are different from that for FGF-2. , 1994, Glycobiology.

[21]  M. Pantoliano,et al.  Identification and concerted function of two receptor binding surfaces on basic fibroblast growth factor required for mitogenesis. , 1994, The Journal of biological chemistry.

[22]  J. Lear,et al.  Multivalent ligand-receptor binding interactions in the fibroblast growth factor system produce a cooperative growth factor and heparin mechanism for receptor dimerization. , 1994, Biochemistry.

[23]  P. Dell’Era,et al.  Distinct role of 2-O-, N-, and 6-O-sulfate groups of heparin in the formation of the ternary complex with basic fibroblast growth factor and soluble FGF receptor-1. , 1994, Biochemical and biophysical research communications.

[24]  M. Pantoliano,et al.  Energetic characterization of the basic fibroblast growth factor-heparin interaction: identification of the heparin binding domain. , 1994, Biochemistry.

[25]  D. Rifkin,et al.  Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding. , 1994, The Journal of biological chemistry.

[26]  B. Olwin,et al.  Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4. , 1993, The Journal of biological chemistry.

[27]  D. Rees,et al.  Three-dimensional structures of acidic and basic fibroblast growth factors. , 1993, Science.

[28]  J. Xu,et al.  An essential heparin-binding domain in the fibroblast growth factor receptor kinase. , 1993, Science.

[29]  L. Cousens,et al.  Preparation of affinity-fractionated, heparin-derived oligosaccharides and their effects on selected biological activities mediated by basic fibroblast growth factor. , 1993, The Journal of biological chemistry.

[30]  J. Turnbull,et al.  Identification of the basic fibroblast growth factor binding sequence in fibroblast heparan sulfate. , 1992, The Journal of biological chemistry.

[31]  J G Flanagan,et al.  Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells , 1992, Molecular and cellular biology.

[32]  Jeffrey D. Esko,et al.  Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor , 1991, Cell.

[33]  M. Jaye,et al.  Effect of heparin on the binding affinity of acidic FGF for the cloned human FGF receptors, flg and bek. , 1990, Biochemical and biophysical research communications.

[34]  M. Petitou,et al.  Heparin‐derived oligosaccharides: Affinity for acidic fibroblast growth factor and effect on its growth‐promoting activity for human endothelial cells , 1989, Journal of cellular physiology.

[35]  J. Folkman,et al.  Importance of size, sulfation, and anticoagulant activity in the potentiation of acidic fibroblast growth factor by heparin. , 1989, Journal of Biological Chemistry.